European Journal of Surgical Oncology · 2018 · 56 citations · 26 references
MedicineOncologyPathologyEndocrine OncologyMolecular OncologyNeoplasiaEndocrine Tumor PrognosisImmune Checkpoint InhibitorsMalignant NeoplasmsThyroid CancerMedullary Thyroid Carcinoma PathologyPd-1 SignalingPd-l1 BlockadePrognostic BiomarkersPrognostic Factors AnalysisProgrammed Cell Death Protein 1 (Pd-1) PathwayProgrammed Death-ligand 1 BiomarkerThyroid Cancer Pathology
26
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer et al. · New England Journal of Medicine · 2012 · 12.7K citations · Full text
Life Sciences, Immunology, Oncology +17
Electron Kebebew, Philip H. G. Ituarte, Allan Siperstein et al. · Cancer · 2000 · 683 citations · Full text
Medicine, Endocrinology, Oncology +11
Prognosis of medullary thyroid carcinoma
Sanziana A. Roman, Rong Lin, Julie Ann Sosa · Cancer · 2006 · 544 citations · Full text
Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas
Andreas H. Scheel, Manfred Dietel, Lukas C. Heukamp et al. · Modern Pathology · 2016 · 350 citations · Full text
Medicine, Cell Biology, Oncology +10